Xtandi - 40 mg soft capsules, Flutamide 250 mg Tablets, Casodex® 50 mg Film-coated Tablets
CTRIAL-IE 14-06
Phase 3 small_molecule active
Quick answer
Xtandi - 40 mg soft capsules, Flutamide 250 mg Tablets, Casodex® 50 mg Film-coated Tablets for Metastatic Prostate Cancer is a Phase 3 program (small_molecule) at Cancer Prevention Pharma (Ireland) Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cancer Prevention Pharma (Ireland) Limited
- Indication
- Metastatic Prostate Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active